Nicotine Reinforcement and Aversion in Young Adult Light Smokers
年轻成年轻度吸烟者的尼古丁强化和厌恶
基本信息
- 批准号:9491785
- 负责人:
- 金额:$ 52.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultBehaviorBehavioralBenefits and RisksCause of DeathChemicalsCigaretteCotinineCross-Over StudiesDevelopmentDoseDouble-Blind MethodDrug KineticsElectronic cigaretteEnrollmentFemaleGenderGoalsHourHumanIntakeIntravenousKnowledgeLightMeasuresMetabolic Clearance RateMetabolismMethodologyModelingNicotineNicotine DependenceNoseOutcomePatient Self-ReportPharmaceutical PreparationsPlacebosPsychological reinforcementPublicationsRandomizedReproducibilityResearchRouteSalineSamplingSampling StudiesScienceSelf AdministrationSelf-AdministeredSmell PerceptionSmokeSmokerSystemTaste PerceptionTobaccoTobacco DependenceVisionYouthaddictionbaseexperimental studyhuman modelhydroxycotinineinterestknowledge basemalenicotine gumnovelpreventpublic policy on tobaccoreinforceryoung adult
项目摘要
Abstract: Nicotine is considered to be the main addictive ingredient in tobacco. Therefore, the nicotine
content of tobacco products may serve as a logical target in the development of effective tobacco-control
policies. In their landmark article, Benowitz and Henningfield (B&H) proposed that the gradual reduction of the
nicotine content of cigarettes to an amount below the threshold addictive dose could prevent the development
of nicotine addiction among young smokers. B&H estimated that the threshold for nicotine addiction is
approximately 0.17 mg of delivered nicotine per cigarette and predicted that nicotine doses below this
threshold would neither be self-administered nor maintain nicotine addiction. Although proposed over 20 years
ago, this estimated threshold for nicotine reinforcement remains to be systematically evaluated by carefully
controlled human studies. Availability of such knowledge would provide a stronger scientific rationale for the
potential risks and benefits of nicotine reduction approaches. This knowledge gap is partly due to the difficulty
in assessing nicotine's reinforcing effects from currently available nicotine delivery systems in humans. While
some nicotine delivery systems are not reliably reinforcing (e.g., nicotine gum or lozenge), others do not deliver
accurate doses of nicotine or deliver many other chemicals in addition to nicotine (e.g., tobacco or e-
cigarettes). To address these limitations, we have developed a novel intravenous (IV) nicotine self-
administration (NSA) model for humans. IV nicotine closely mimics both the pharmacokinetics and behavioral
effects of smoked nicotine, including reinforcement. The main goal of this project is to use IV NSA for
estimating threshold reinforcing doses of nicotine and to generate dose-effect curves for low doses of nicotine
in smokers. This application will also examine if the nicotine reinforcement threshold and dose-effect curve
varies with gender and with the rate of nicotine metabolism. The study sample will be young adult male and
female light and intermittent smokers (LITS), also known as `chippers', who show few or no signs of addiction.
We propose a double-blind, placebo-controlled, crossover study that will enroll 36 male and 36 female LITS.
Smokers will participate in five experimental sessions. In each session, they will first sample the assigned
nicotine dose and the placebo (saline) dose followed by the opportunity to choose between nicotine and
placebo administrations. The knowledge gained from this study will be useful in guiding strategies that lower
nicotine content of tobacco products in order to reduce their addictive potential.
摘要:尼古丁被认为是烟草中的主要成瘾成分。因此,尼古丁
烟草产品的含量可以作为开发有效烟草控制的逻辑目标
政策。 Benowitz和Henningfield(B&H)在其具有里程碑意义的文章中提出,逐渐减少
香烟的尼古丁含量达到阈值上瘾剂量以下
年轻吸烟者中的尼古丁成瘾。 B&H估计尼古丁成瘾的阈值是
每烟大约0.17毫克递送的尼古丁,并预测尼古丁剂量以下
阈值既不会自我管理也不会维持尼古丁成瘾。虽然提议超过20年
以前,尼古丁加固的估计阈值仍有待仔细地评估
受控人类研究。此类知识的可用性将为您提供更强的科学原理
尼古丁减少方法的潜在风险和益处。这些知识差距部分是由于困难
在评估人类目前可用的尼古丁输送系统中尼古丁的增强作用时。尽管
某些尼古丁输送系统没有可靠的加固(例如尼古丁口香糖或润滑剂),而另一些则没有交付
精确剂量的尼古丁或除尼古丁外(例如烟草或e-)外,还提供许多其他化学物质
香烟)。为了解决这些局限性,我们开发了一种新颖的静脉(IV)尼古丁自我
人类的管理(NSA)模型。静脉注射尼古丁密切模仿药代动力学和行为
烟熏尼古丁的影响,包括加固。该项目的主要目标是将IV NSA用于
估计阈值加强尼古丁的剂量,并为低剂量的尼古丁产生剂量效应曲线
在吸烟者中。该应用还将检查尼古丁增强阈值和剂量效应曲线是否
随性别和尼古丁代谢率而变化。研究样本将是年轻的成年男性,
女性轻巧和间歇性吸烟者(LITS),也称为“芯片”,她们几乎没有成瘾的迹象。
我们提出了一项双盲,安慰剂对照的跨界研究,该研究将注册36名男性和36位女性lits。
吸烟者将参加五次实验会议。在每个会话中,他们将首先采样分配的
尼古丁剂量和安慰剂(盐水)剂量,然后有机会在尼古丁和
安慰剂管理。从这项研究中获得的知识将有助于指导降低的策略
烟草产品的尼古丁含量,以降低其上瘾的潜力。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Threshold for the pleasurable effects of nicotine are lower than its reinforcing effects during self-administration.
尼古丁的愉悦效果阈值低于其自我给药期间的增强效果。
- DOI:10.1037/pha0000556
- 发表时间:2023
- 期刊:
- 影响因子:2.3
- 作者:MacLean,RRoss;Eid,Tore;Parida,Suprit;Gueorguieva,Ralitza;DeVito,EliseE;Sofuoglu,Mehmet
- 通讯作者:Sofuoglu,Mehmet
Threshold dose for intravenous nicotine self-administration in young adult non-dependent smokers.
- DOI:10.1007/s00213-021-05833-8
- 发表时间:2021-08
- 期刊:
- 影响因子:3.4
- 作者:MacLean RR;DeVito EE;Eid T;Parida S;Gueorguieva R;Sofuoglu M
- 通讯作者:Sofuoglu M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mehmet Sofuoglu其他文献
Mehmet Sofuoglu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mehmet Sofuoglu', 18)}}的其他基金
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
IV 脉冲尼古丁作为吸烟模型:剂量和输送率的影响
- 批准号:
10350261 - 财政年份:2021
- 资助金额:
$ 52.42万 - 项目类别:
Nicotine Reinforcement and Aversion in Young Adult Light Smokers
年轻成年轻度吸烟者的尼古丁强化和厌恶
- 批准号:
9193853 - 财政年份:2016
- 资助金额:
$ 52.42万 - 项目类别:
Progesterone Augmentation for Smoking Cessation in Women
增加黄体酮有助于女性戒烟
- 批准号:
8957427 - 财政年份:2015
- 资助金额:
$ 52.42万 - 项目类别:
Progesterone Augmentation for Smoking Cessation in Women
增加黄体酮有助于女性戒烟
- 批准号:
9127895 - 财政年份:2015
- 资助金额:
$ 52.42万 - 项目类别:
Cholinergic Enhancement as Treatment for Nicotine Addiction
增强胆碱能治疗尼古丁成瘾
- 批准号:
8582890 - 财政年份:2013
- 资助金额:
$ 52.42万 - 项目类别:
Research Project 3 : Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
研究项目 3:尼古丁输送率及其滥用潜力:薄荷醇的影响
- 批准号:
10242020 - 财政年份:2013
- 资助金额:
$ 52.42万 - 项目类别:
Addictive Threshold of Nicotine and the Impact of Sweeteners
尼古丁的成瘾阈值和甜味剂的影响
- 批准号:
10666236 - 财政年份:2013
- 资助金额:
$ 52.42万 - 项目类别:
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
认知增强作为可卡因药物治疗的目标
- 批准号:
8105851 - 财政年份:2011
- 资助金额:
$ 52.42万 - 项目类别:
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
认知增强作为可卡因药物治疗的目标
- 批准号:
8433410 - 财政年份:2011
- 资助金额:
$ 52.42万 - 项目类别:
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
认知增强作为可卡因药物治疗的目标
- 批准号:
8608508 - 财政年份:2011
- 资助金额:
$ 52.42万 - 项目类别:
相似国自然基金
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于行为整合理论的成人睡眠素养提升机制及实证研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于行为整合理论的成人睡眠素养提升机制及实证研究
- 批准号:72204117
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
羽毛球运动对成人视运动知觉可塑性的影响:行为和神经机制研究
- 批准号:31471003
- 批准年份:2014
- 资助金额:70.0 万元
- 项目类别:面上项目
社区医务人员干预成人超重和肥胖的行为机制:基于计划行为理论的实证研究
- 批准号:71303250
- 批准年份:2013
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The neural underpinnings of speech and nonspeech auditory processing in autism: Implications for language
自闭症患者言语和非言语听觉处理的神经基础:对语言的影响
- 批准号:
10827051 - 财政年份:2024
- 资助金额:
$ 52.42万 - 项目类别:
Longitudinal Modeling of Pro-Inflammatory Cytokines, Hazardous Alcohol Use, and Cerebral Metabolites as Predictors of Neurocognitive Change in People with HIV
促炎细胞因子、有害酒精使用和脑代谢物的纵向建模作为 HIV 感染者神经认知变化的预测因子
- 批准号:
10838849 - 财政年份:2024
- 资助金额:
$ 52.42万 - 项目类别:
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 52.42万 - 项目类别: